The nuclear presence of the expanded disease proteins is of critical importance for the pathogeneses of polyglutamine diseases. Here we show that protein casein kinase 2 (CK2)-dependent phosphorylation controls the nuclear localization, aggregation and stability of ataxin-3 (ATXN3), the disease protein in spinocerebellar ataxia type 3 (SCA3). Serine 340 and 352 within the third ubiquitin-interacting motif of ATXN3 were particularly important for nuclear localization of normal and expanded ATXN3 and mutation of these sites robustly reduced the formation of nuclear inclusions; a putative nuclear leader sequence was not required. ATXN3 associated with CK2a and pharmacological inhibition of CK2 decreased nuclear ATXN3 levels and the formation of nuclear inclusions. Moreover, we found that ATXN3 shifted to the nucleus upon thermal stress in a CK2-dependent manner, indicating a key role of CK2-mediated phosphorylation of ATXN3 in SCA3 pathophysiology.
INTRODUCTION
Spinocerebellar ataxia type 3 (SCA3 or Machado -Joseph disease, MJD) is the most common dominantly inherited ataxia. Like Huntington's disease (HD), spinobulbar muscular atrophy (SBMA) and other ataxias, SCA3 is caused by a translated unstable CAG trinucleotide repeat expansion. The resulting polyglutamine (polyQ) expansions render the respective proteins susceptible to adopt abnormal conformations and promote the occurrence of mainly neuronal (intranuclear) inclusions (NI) (1) . Despite this unifying feature, specific populations of neurons are affected in different polyQ diseases, suggesting that protein sequences outside the polyQ tract contribute to the disease process. Posttranslational modifications of the expanded disease proteins may also modify the pathogenesis: for instance, phosphorylation of a critical serine in ataxin-1 modulates the interaction with a 14-3-3 protein and determines the onset of pathogenic changes in SCA1 mice (2, 3) .
The disease protein in SCA3, ataxin-3 (ATXN3), is a ubiquitin protease involved in transcriptional regulation (4) (5) (6) . ATXN3 interacts with the valosin-containing protein (VCP/ p97), modulates relocation of ERAD substrates and participates in ubiquitin-dependent protein surveillance and quality control pathways (7 -9) . ATXN3 thus serves nuclear and cytoplasmic functions. It is unknown, however, how the subcellular distribution of ATXN3 is regulated. This is particularly important for SCA3 patients, as nuclear presence of polyQ-expanded proteins represents an important component of polyQ toxicity and nuclear presence of ATXN3 is required for the manifestation of symptoms in SCA3 transgenic mice (2, 10) . We here provide evidence that CK2-dependent phosphorylation controls nuclear localization, inclusion formation and stability of ATXN3.
RESULTS

Phosphorylation of ATXN3 by CK2
Phosphorylation prediction software and NanoLCelectrospray-mass spectrometry were used to identify putative phosphorylation sites in ATXN3, among them four conserved CK2 sites at T207, T277, S236 and S340 located in the Cterminus (CT) (Fig. 1A) . Full-length (FL) ATXN3 and the CT of ATXN3 were phosphorylated by CK2 in vitro, while the N-terminus (NT) of ATXN3 was not phosphorylated (Fig. 1B) . Presenilin2, a known CK2 substrate, served as positive control. In contrast, no phosphorylation of FL-ATXN3 was observed with protein kinase A (PKA), while the PKA substrate histone H3 was phosphorylated (Supplementary Material, Fig. S1 ).
Analysis of in vivo phosphorylation of FL, NT and CT ATXN3-Q19, respectively, in transiently transfected HEK293 cells confirmed the selective phosphorylation of the CT of ATXN3 (Fig. 1C) . ATXN3-Q19 wild type (WT) and ATXN3-Q70 WT were phosphorylated with similar efficacy (Supplementary Material, Fig. S2 ).
Phosphoamino acid analysis of in vivo radiolabeled ATXN3-Q19 revealed only serine but no tyrosine or threonine residues as putative phosphorylation sites (Fig. 1D ). Subsequent consecutive site-directed mutagenesis of 15 putative serine phosphorylation sites revealed a robust reduction of phosphate incorporation at S340A and S352A in vivo. Both residues are located within the third ubiquitin-interacting motif (UIM) of ATXN3 isoform 1 (11) . Additional significant phosphorylation was found at S236, located within the first UIM, as well as S256 and S260/S261, located within the second UIM (Fig. 1E) . In contrast, S265A, S272A, S278A, S312A/S313A, S314A/S317A/S318A, S322A/S323A and S328A showed little or basically no reduction of [ 32 P]orthophosphate incorporation (representative phosphorylation intensities shown in Supplementary Material, Fig. S3 ). The main phosphorylation of ATXN3 in vivo thus occurred at serine residues within the three conserved UIMs.
Two peptide-specific antibodies raised against amino acids 334 -340 (DLGDAM(pS)EEDMLQA) and amino acids 348 -363 (AVTM(pS)LETVRNDLKTE) protected endogenous ATXN3 against dephosphorylation. ATXN3 was labeled with 32 P, immunoprecipitated and incubated w/o 1E8 (S340) and 2D5 (S352) followed by treatment with alkaline phosphatase (SAP). The antibodies 1E8 and 2D5 protected against the loss of the radioactive signal brought about by alkaline phosphatase treatment while the NT ATXN3 antibody did not, indicating that precipitated ATXN3 was phosphorylated at S340 and S352 in vivo (Fig. 1F) .
Pull-down experiment of His-ATXN3-Q19-WT, overexpressed in ATXN3 knockout mouse embryonic fibroblasts (ko-MEF) cells, pulled with NiNTA and subsequent western blot analysis with anti-CK2a showed that CK2a associated with ATXN3 ( Fig. 1G) (12) . In addition, we performed immunoprecipitation with an ATXN3 antibody (986), bound to A-protein agarose in wt-MEF cells to analyze endogenous ATXN3 interaction with CK2. Subsequent western blots 32 P]-labeled His-ATXN3 from transfected HEK293 cells was excised after blotting, hydrolyzed and electrophoretically separated on a cellulose-TLC plate and visualized by radiography. The position of the phospho-amino acid standards (P-Ser, P-Thr, P-Tyr) in the marker lane (M) are indicated by triangles. (E) Potential serine phosphorylation sites were analyzed by in vivo phosphorylation of individual and combined alanine mutants of His-ATXN3-Q19 as indicated. [
32 P]-labeled His-ATXN3 from transfected HEK293 cells was detected by radiography ( 32 P) and Western blot (WB) with an anti-His antibody. The S352A mutation evoked a change in electrophoretic mobility, possibly due to a SDS-resistant conformational change. Incorporation of 32 P was quantified densitometrically and normalized to the respective immunoreactive signal intensity obtained by WB. Values are expressed as percentage (%) of 32 P incorporation in wild-type ATXN3-Q19 (WT) (mean + SEM of three independent experiments). (F) Wild-type MEF were incubated with 32 P, endogenous ATXN3 was immunoprecipitated and incubated w/o polyclonal N-terminal ATXN3-specific antibody (NT), the ATXN3 peptide-specific antibodies 1E8 or 2D5 followed by treatment with alkaline phosphatase. The antibodies 1E8 and 2D5 protected against the loss of the radioactive signal brought about by alkaline posphatase treatment while the NT ATXN3-antibody did not, indicating that precipitated ATXN3 was phosphorylated at S340 and S352 in vivo. (G) Pull-down experiments using ATXN3 knockout mouse embryonic fibroblasts (ATXN3-ko-MEF) transiently transfected with His-ATXN3-Q19-WT or empty vector. (His-ATXN3-Q19-WT was precipitated with Ni-NTA and followed by Western blot to visualize ATXN3 with anti-His antibody and co-precipitated CK2-alpha with antibody CK2alpha. Anti-CK2-a labeled two bands (a and a 0 subunit). (H) ATXN3 transiently expressed in ATXN3-ko-MEFs was immunoprecipitated using an ATXN3-specific antibody (986) and bound to A-protein agarose. Subsequent western blot was used to visualize ATXN3 with anti-His antibody and CK2-a/b with antibodies CK2-a and -b. The CK2-a antibody identified two distinct bands while the CK2-b antibody gave only a very weak signal.
with anti-CK2a identified two distinct bands (a and a 0 subunit) while anti-CK2b gave only a very weak signal (Fig. 1H) . The results suggest that ATXN3 associated mainly with the CK2a subunit.
Phosphorylation increased nuclear levels of ATXN3
Expression of alanine mutants of ATXN3 in ko-MEF, excluding a mutual interaction with endogenous ATXN3, showed that mutation of all six serines in the three UIMs (ATXN3-All) to alanine resulted in a predominant nuclear localization, while the respective aspartate mutant was located predominantly in the cytoplasm (Supplementary Material, Fig. S4 ). This distinctive subcellular distribution was most profound with ATXN3-Q19-S340A/S352A and ATXN3-Q19-S340D/S352D, respectively (Fig. 3A -F , Supplementary Material, Fig. S4 ). Similar data were obtained for expanded ATXN3 both in MEF and HEK293 cells (Fig. 2D -F and Supplementary Material, Fig. S4 ).
Western blot analysis of subcellular fractions of transfected ko-MEF cells confirmed reduced nuclear levels and preferential cytoplasmic localization of ATXN3-Q19-S340A/S352A in comparison with ATXN3-Q19-S340D/S352D (Fig. 2M) . Although less distinct, ATXN3-Q19-S236A was also found preferentially in the cytoplasm while ATXN3-Q19-S236D increased in the nuclear fraction. In contrast, the distribution of ATXN3-Q19-S256A/S260A/S261A and ATXN3-Q19-S256D/S260D/S261D were not changed (Fig. 2M) .
Similar results were obtained with expanded ATXN3: all ATXN3 proteins containing S340A/S352A showed robustly reduced levels in the nuclear fraction (Supplementary Material, Figs S4 and S5) .
The plasmids containing the alanine and aspartate mutants of ATXN3 were expressed with similar efficacy, resulting in comparable levels of the respective proteins (Supplementary Material, Fig. S5 ). These findings suggest that phosphorylation at residues S340/S352 and S236 (within the third and first UIM, respectively) increases the nuclear presence of ATXN3 whereas residues S256/S260/S261 (within the second UIM) are of minor importance for subcellular localization.
Phosphorylation of ATXN3 increased nuclear inclusions formation C-terminus fragments of ATXN3 have been shown to form inclusions in cultured cells (11, 13) . We thus used a CT-ATXN3 fragment (ATXN3-257Q70) to investigate whether phosphorylation would modulate inclusion formation. Mutation of a highly conserved putative nuclear localization signal (NLS) in ATXN3 at amino acids 282-285 (RKRR. HNHH) had no effect on subcellular distribution (Fig. 2J -L). To investigate whether this NLS might be unmasked or activated by phosphorylation (or heat shock, Fig. 5E ), we created additional NLS mutants of ATXN3-Q19-S340D/ S352D and ATXN3-257Q70-S340D/S352D. Mutation of this presumed NLS did not change the nuclear presence of the respective proteins ( Fig. 2K and L) . Also, inclusions formed upon expression of ATXN3-257Q70-S340D/S352D-HNHH were located preferentially in the nucleus of ATXN3 ko-MEF (Fig. 2L) , indicating that RKRR at amino acid 282-285 do not function as a necessary NLS in ATXN3.
Inhibition of CK2 reduced nuclear abundance of ATXN3 and inclusion formation
We next investigated whether pharmacological inhibition of CK2 is sufficient to alter nuclear steady-state levels of ATXN3. The two selective CK2 inhibitors 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazol (DMAT) and 4,5,6,7-tetrabromobenzotriazole (TBB), both decreased the abundance of nuclear ATXN3-Q19-WT and almost abolished the occurrence of ATXN3-257Q70 inclusions in the nucleus (Figs 3A and B, 4A and B and Supplementary Material, Fig. S7 ). DMAT is considered the most potent and selective CK2 inhibitor available (IC 50 0.15 mM) whereas TBB is reported to be effective on cultured cells at 25-50 mM concentration and inhibits GSK3 at higher concentrations (14) . DMAT in a concentration of 0.2 mM reduced CK2 activity in transfected ko-MEF by approximately 80% (Supplementary Material, Fig. S8 ). Inhibition of CK2 in non-transfected native wt-MEF and CSM14.1 cells resulted in decreased nuclear staining of ATXN3, indicating that inhibition of CK2 is sufficient to modulate nuclear localization of endogenous ATXN3 (Fig. 4C -F Thermal stress increased nuclear abundance of ATXN3 in a CK2-dependent manner CK2 is constitutively active but can be activated further under certain conditions. Thermal stress has been shown to re-locate CK2 to specific components of the nuclear matrix and to increase nuclear CK2 activity (15) . Exposure to elevated temperature (heat shock for 5 -60 min at 428C) increased the nuclear abundance of WT ATXN3, but not of the non-phosphorylatable alanine mutant of ATXN3 (Fig. 5A and B, Supplementary  Material, Fig. S9) . Likewise, the shift of WT ATXN3 into the nucleus upon thermal stress was suppressed by pharmacological inhibition of CK2 (Fig. 5C and D) . Re-location of CK2 to the nucleus was not affected (Fig. 5 and Supplementary  Material, Fig. S9 ). Increased activity of CK2 thus increased nuclear presence of ATXN3. The putative NLS was not required under heat shock conditions either (Fig. 5E) .
Phosphorylation modulated the stability of ATXN3
To address the question whether phosphorylation of ATXN3 might affect the protein's stability, we used a pulse-chase approach. Over a time course of 36 h, ATXN3-Q19-S340A/ S352A was degraded more rapidly than ATXN3-Q19-WT (Fig. 6) . The calculated half-life of ATXN3-Q19-S340D/ S352D was increased to 63.4 h compared with 28.4 h of ATXN3-Q19-WT and 19.1 h of ATXN3-Q19-S340A/S352A.
Phosphorylation of ATXN3 enhanced transcriptional repression of MMP-2
We had shown previously that ATXN3 represses MMP-2 transcription through chromatin binding and interaction with HDAC3 (6). Compared with ATXN3 WT, expression of nonphosphorylatable ATXN3-Q19-S236A/S340A/S352A reduced repression of MMP2 gene expression in luciferase reporter assays, while the phospho-mimic ATXN3-S236D/S340D/ S352D had the opposite effect (Fig. 7A) . Phosphorylation thus strengthened the transcriptional activities of ATXN3 and may also increase the aberrant transcriptional effects of expanded ATXN3. In addition, pharmacological inhibition of CK2 in native CSM14.1 cells, containing endogenous ATXN3 only, activated MMP-2 transcription, suggesting that CK2 is indeed an in vivo kinase for ATXN3 (Fig. 7B) .
Identified CK2-phosphorylation sites of ATXN3 had no effect on known protein interactions
In line with earlier data by Chai et al. (16) , who found the third UIM dispensable for ubiquitin binding, mutation of S340 and S352 to alanine or aspartate had no effect on the ubiquitinbinding capability of ATXN3 (Fig. 8A) . On the other hand, mutation of phosphorylation sites in the second UIM (S256A/S260A/S261A) restricted ubiquitin binding to higher molecular weight chains (n . 3), confirming the observations of Mao et al. (17) (Fig. 8A) .
Mutation of the six serine residues located in the first to third UIM had no obvious effect on the association of ATXN3-Q19-S236A/S340A/S352A or ATXN3-Q70-WT respectively, heat shocked at 428C for 30 min and after heat shock, HEK293 cells were followed up to 60 min. Heat shock increased nuclear abundance of ATXN3-Q19-WT and ATXN3-Q70-WT (and CK2), whereas ATXN3-Q19-S236A/S340A/S352A was not affected. (B) Quantification of the ATXN3 and CK2a from the above nuclear and cytoplasmic fractions of HEK 293 cells transfected with His-ATXN3-Q19-WT, His-ATXN3-Q19-S236A/S340A/S352A or His-ATXN3-Q70-WT, respectively, after heat shock as described above. In contrast to wild-type ATXN3-Q19 and -Q70, the alanine mutant His-ATXN3-Q19-S236A/S340A/ S352A was not affected by the heat shock and did not relocate to the nucleus. Intensities of ATXN3 and CK2a immunoreactive signals on WB were quantified densitometrically and values expressed as ATXN3 (CK2a) percentage (%) based on total nuclear and cytoplasmic quantification. Error bars represent mean and SD of three independent experiments. (C) Western blot of nuclear and cytoplasmic fractions of HEK293 cells transfected with His-ATXN3-Q19-WT heat shocked at 428C for 30 min, having been treated w/o TBB to inhibit CK2 for 60 min prior heat shock. Pharmacological inhibition of CK2 inhibited the transfer of ATXN3 to the nucleus even having been heat shocked, while having no impact on the nuclear relocation of CK2. (D) Quantification of the ATXN3 and CK2a from the above nuclear and cytoplasmic fractions of HEK293 cells transfected with His-ATXN3-Q19-WT after heat shock and TBB treatment as described above. Heatshock did not invoke nuclear localization ATXN3-Q19-WT treated with TBB. Intensities of ATXN3 and CK2a immunoreactive signals on WB were quantified densitometrically and values are expressed as ATXN3 (CK2a) percentage (%) based on total nuclear and cytoplasmic quantification. Error bars represent mean and SD of three independent experiments. (E) Mutation of the conserved putative NLS at amino acids 282-285 (RKRR.HNHH) had no effect on the subcellular distribution of ATXN3 upon heat shock. ATXN3 with known interacting proteins. Similar to normal ATXN3-Q19-WT, ATXN3-Q19-All (alanine) was co-immunoprecipitated with RAD23B, HDAC3 and VCP/ p97 (Fig. 8B -D) and also the all-aspartate mutant of ATXN3-Q19 associated with RAD23B, HDAC3 and VCP/ p97 in whole cell lysates. No association of any ATXN3 isoform with 14-3-3zeta-like was found (data not shown) and neither one-dimensional SDS -PAGE (Fig. 8E) or 2D gel electrophoresis identified differentially bound proteins (data not shown).
DISCUSSION
We identified CK2 as a regulator of nuclear localization of ATXN3 and showed that CK2-dependent phosphorylation of ATXN3 at S236 and S340/S352 within the first and third UIM modulated nuclear abundance of ATXN3, the occurrence of nuclear inclusions and controlled the nuclear translocation of ATXN3 upon thermal stress. No effect of the polyQ expansion was found: similar to the first report of phosphorylation of ATXN3 by Trottier et al. (18) , we observed that normal and expanded ATXN3 were phosphorylated with similar efficacy.
ATXN3 is a multifunctional, deubiquitinating and polyubiquitin-chain binding protein (4) (5) (6) (7) (8) (9) (10) (11) (12) . Binding of polyubiquitinated substrates is mediated predominantly by S256 in the second UIM and to a lesser degree by S236 in the first UIM, while the third UIM has been suggested to play only a minor role (17, 18) . It was thus interesting to find the most intensely phosphorylated serine residues at S340 and S352 within the third UIM. In line with earlier data, mutation of S340 and S352 to A340 and A352, respectively, had no effect on ubiquitin binding but turned out to be sufficient to modulate nuclear abundance and stability of ATXN3. A major function of phosphorylation of the CK2-motifs within the third UIM could thus be to increase the nuclear presence of ATXN3.
Proteins may enter the nucleus via simple diffusion (up to a critical mass of approximately 75 kDa) or are transported actively through the nuclear pore complexes (19) . The classic nuclear protein import pathway requires binding of the cytoplasmic importins to an NLS to facilitate the transport through the nuclear pore. Although the putative NLS in ATXN3 (amino acid 282-285: RKRR) is highly conserved, mutation of this motif did not decrease the nuclear abundance of ATXN3, neither in steady conditions or upon heatshock, suggesting that this NLS is not required for nuclear import of ATXN3. In addition, we observed in preliminary experiments that inhibition of importin-dependent nuclear import by OA did not reduce nuclear steady-state levels of ATXN3-Q19-WT (Supplementary Material, Fig. S5 ) (20) .
Phosphorylation appeared to stabilize ATXN3. We observed in pulse-chase experiments, that the phospho-mimic aspartate mutant had a significantly prolonged apparent halflife compared with the non-phosphorylatable alanine mutant (63 versus 19 h). In addition, the presence of the third UIM in isoform 1 increased the stability of ATXN3 compared with isoform 2 (without the third UIM; data not shown). In SCA1, phosphorylation at S776 mediates the interaction of ATXN1 with the regulatory molecule 14-3-3, promoting the stabilization and nuclear accumulation of ATXN1 and enhancing inclusions formation (3). However, our experiments showed no association of ATXN3 with 14-3-3 and neither 1D SDS-PAGE nor initial 2D gel electrophoresis experiments revealed putative phospho-specific interacting partners of ATXN3. In addition, the all-alanine and all-aspartate mutants of ATXN3 showed a comparable association with the known interacting proteins VCP/p97, RAD23B and HDAC3.
The effect of phosphorylation on nuclear abundance of ATXN3 raised the question of the impact of phosphorylation on macroscopic inclusions formation. Mimicking phosphorylation at S340/S352 with aspartate (D) mutants increased ATXN3-Q19 levels in the nucleus and also increased nuclear inclusions formation by ATXN3-257Q70. In contrast to SCA1, where the S776A mutant form of ATXN1 was diffusely distributed in nuclei of transfected cells but was not found in inclusions, ATXN3-S340A/S352A was found preferentially in the cytoplasm and ATXN3-257Q70-S340A/S352A formed inclusions also preferentially in the cytoplasm. Therefore, inhibition of phosphorylation of ATXN3 had a strong effect on the localization but did not abolish the occurrence of inclusions. Fei et al. (21) reported that phosphorylation at S256 by GSK3ß might increase the solubility of ATXN3 in vitro and hypothesized that phosphorylation of S256 could regulate aggregation. Our data demonstrate that slower turnover of phosphorylated ATXN3 and increased nuclear presence enhanced the formation of inclusions. A less stringent protein quality surveillance in the nucleus when compared (18 h), but the turnover rate of ATXN3-Q19-S236D/S340D/S352D was significantly decreased indicating a slower turnover rate for phosphorylated ATXN3 in cells (28) .
with the cytoplasm, less chaperone and autophagy activity in the nucleus may further contribute to increased nuclear presence and the occurrence of preferential nuclear inclusions observed in SCA3 (22) .
Additional experiments addressed the question whether phosphorylation-dependent cellular localization of ATXN3 would affect its presumed nuclear function. We have shown previously that ATXN3 acts as a nuclear co-repressor for matrix-metalloproteinase 2 (MMP2) gene expression and CK2 has already been identified as an early mediator of the UVB-dependent up-regulation of MMP-1 and MMP-3 translation (6, 23) . Phosphorylation indeed enhanced the transcriptional repressor activity of ATXN3 and may also increase the aberrant transcriptional effects of expanded ATXN3, which probably contribute to the long-term toxicity in SCA3.
CK2 is constitutively active and participates in many cellular processes including replication, transcription, translation and signal transduction (24) . CK2 has been denoted a nuclear protein kinase and the nucleus constitutes a focus of CK2 activity (25) . The decrease of the nuclear abundance of endogenous ATXN3 observed with the CK2 inhibitors DMAT and TBB implies that constitutively active CK2 keeps a fraction of phosphorylated ATXN3 in the nucleus. The finding that thermal stress or 'heat shock' increased the nuclear presence of ATXN3 in a CK2-dependent manner, points to ATXN3 as a component of a nuclear protein network that is phosphorylated by CK2 upon proteotoxic stress. ATXN3 has been implicated in protein quality control-it is therefore tempting to speculate that expression of the polyQ expanded ATXN3 could induce a vicious cycle of protein folding stress, impaired protein quality control and increased CK2 activity which further promotes the nuclear localization of ATXN3 and may impair ATXN3 degradation.
We cannot exclude at the present that additional kinases downstream of CK2 are involved in a consecutive phosphorylation process of ATXN3 as the molecular mechanisms involved in the array of pathways modulated by CK2 have not been fully elucidated. Nevertheless, pharmacological modulation of the subcellular distribution of ATXN3 via CK2 activity appears to provide a reasonable therapeutic approach for SCA3 for several reasons: ATXN3 was phosphorylated by CK2 in vitro, associated with the CK2a subunit and pharmacological inhibition of CK2 had a similar effect on subcellular distribution of ATXN3 as S.A mutations. Further, the CK2 inhibitors DMAT and TBB resulted in a substantial decrease of the nuclear abundance of WT ATXN3 and ATXN3-257Q70-WT in cultured cells and modulated the transcriptional repressor activity of ATXN3. Natural flavonoids with CK2 inhibiting properties have been tested against pancreatic cancer in vitro and are used as OTC food supplement because of their presumed antioxidative and anti-inflammatory properties (26) . These compounds may be suitable for long-term use and studies in transgenic murine models are required to find out whether a moderate inhibition of CK2 could be sufficient to ameliorate the course of SCA3.
EXPERIMENTAL PROCEDURES
Cell culture and chemicals
Human embryonic kidney cells (HEK293), rat CSM14.1 and mouse embryonic fibroblasts (MEF) were maintained as described (6, 12) . FuGENE 6 (Roche) was used for transfections; 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT; 0,02-1 mM), 4,5,6,7-tetrabromobenzotriazole (TBB, 2-10 mM) and okadaic acid (OA 0.5 mM) were applied for the indicated times 24 or 48 h after transfection. Heat shock was induced at 428C for 30 min in a water bath.
Expression constructs
Expression constructs encoding C-terminal His 6 -tagged fulllength human normal or expanded ATXN3 were generated by subcloning the SCA3 cDNA BamHI/AgeI inserts of pBI-SCA3-Q19 and -Q70 into pcDNA3.1-His (Invitrogen); these constructs were used further to substitute the potential phosphorylation sites of ATXN3Q19 and ATXN3Q70 with either alanine or aspartate by site-directed mutagenesis (Stratagene). GST-ATXN3 fusion constructs for bacterial expression were generated by subcloning the SCA3 cDNA inserts into pGEX-5X-1 (Amersham).
Protein expression and analyses
GST -ATXN3 fusion proteins were expressed in Escherichia coli BL21 and purified using glutathione sepharose 4B beads according to the manufacturer's instructions (Amersham). Western blot, immunoprecipitations with Protein A agarose and Ni-nitrilotriacetic acid (NTA) pulldown assays were performed as described with mouse monoclonal anti-ATXN3 (1H9, Chemicon), anti-ATXN3 (986 (13)), anti-His (Qiagen), anti-actin (all isoforms; Sigma), anti-GST (Amersham), anti-myc (Santa Cruz), anti-ATXN3 (NT-MJD), antiHistone H3 (Santa Cruz), anti-RAD23B (E. Wanker, MDC, Berlin), anti-HDAC3 (Active Motif), anti-VCP (Santa Cruz), anti-CK2-alpha (Santa Cruz) antibodies and rabbit control IgG (Santa Cruz) (6, 12) . Peptide-specific antibodies were raised in mice against phosphorylated or unphosphorylated amino acids 334-340 (DLGDAM(pS)EEDMLQA) and amino acids 348 -363 (AVTM(pS)LETVRNDLKTE) in collaboration with Y. Trottier (INSERM; Strasburg, France (18)).
Subcellular fractionation
Transiently transfected cells were scraped into cold PBS, centrifuged at 2000g for 5 min and the cell pellet was resuspended into hypotonic buffer A (10 mM HEPES, pH 7.9/1.5 mM The first and third UIM of ATXN3 (S236, S340/S352) harbor the main phosphorylation sites and mutation of S340 and S352 in the third UIM was sufficient to modulate the subcellular localization of ATXN3. The third UIM has been shown to be irrelevant for the binding of polyubiquitinated substrates (16, 17) while S256 in the second UIM was considered most important. Accordingly, co-immunoprecipitation of synthetic K48-poly ubiquitin-linked chains with ATXN3-Q19-WT and the mutant ATXN3-Q19-S256A/S260A/S261A, ATXN3-Q19-S340A/S352A and ATXN3-Q19-S340D/S352D proteins confirmed that the alanine and aspartate mutants-within the 3 rd UIM (S340A/S352A and S340D/S352D)-had no effect on ubiquitin binding. (B-D) Preventing phosphorylation at all six serines (236/256/260/261/340/352) located in the three UIMs had no obvious effect on protein-protein interactions. We found similar associations of the respective alanine and aspartate mutants of ATXN3 with the known interacting proteins RAD23B (B), HDAC3 (D) and VCP/p97 (C). ATXN3-Q19-All was co-immunoprecipitated with these interacting proteins similar to normal ATXN3-Q19-WT. (E) One-dimensional SDS-PAGE of lysates from co-immunoprecipitation assays did not identify differentially proteins bound by ATXN3-Q19-All-alanine or ATXN3-Q19-All-aspartate (indicated by arrowheads).
MgCl 2 /10 mM KCl/0.1% NP-40/0.5 mM DTT/0.1% Triton X-100), homogenized with a syringe and incubated for 10 min on ice. Lysates were centrifuged at 2000g for 5 min. Supernatants were saved as cytosolic fractions. The pellet was washed three times with hypotonic buffer A and resuspended in buffer B (20 mM HEPES, pH 7.9/420 mM NaCl/ 25% glycerol/1.5 mM MgCl 2 /0.2 mM EDTA), incubated for 20 min on ice and centrifuged for 30 min at 12 000g. Supernatants were saved as nuclear fractions.
Phosphorylation
The phosphorylation prediction software NetPhos 2.0 and DISPHOS 1.3 (http://www.cbs.dtu.dk/services/NetPhosK and http://core.ist.temple.edu/pred) were used to identify putative phosphorylation sites in ATXN3. In vitro phosphorylation was performed with 5 mg purified GST-ATXN3 attached to glutathione agarose beads, 3 ml (1 mCi) [g 32 ]-ATP, 2 ml kinase buffer, 2 U of CK2 or PKA, respectively, and ddH 2 O to a total volume of 20 ml. Samples were incubated at 308C for 30 min, beads were washed with RIPA buffer, resuspended in loading buffer and separated by SDS-PAGE. In vivo phosphorylation was performed with transiently transfected HEK293 cells expressing His-ATXN3. After 24 h cells were incubated for 60 min in phosphate-free medium (Sigma) which was replaced with phosphate-free medium containing 1 mCi [ 32 P]-orthophosphate (Amersham) for another 3 h. Cells were washed once with PBS and lysed with RIPA buffer on ice. His-ATXN3 was precipitated with Ni-NTA agarose, dissolved in two times Laemmli loading buffer and radiolabeled proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes and visualized by autoradiography.
Phosphoamino acid analysis
[ 32 P]-labeled His-ATXN3 was isolated by Ni-NTA, separated by SDS-PAGE, transferred to PVDF membranes and localized by autoradiography. The corresponding band was excised and phospho-amino acid analysis was performed according to Boyle et al. (27) . The labeled protein was hydrolyzed by incubation in 6 M HCl for 90 min at 1108C. The supernatant was dried in a SpeedVac concentrator. The resulting pellet was dissolved in electrophoresis buffer (5.9% acetic acid/0.3% formic acid/0.3% pyridine/0.3 mM EDTA) and spotted onto thin-layer cellulose plates (Merck) together with unlabeled phospho-amino acid standards (P-Ser, P-Thr, P-Tyr; 1 mg each). High-voltage electrophoresis was carried out for 1 h at 1.4 kV, 40 mA. Radioactive phospho-amino acids were identified by autoradiography and compared with ninhydrine-stained standards.
Immunocytochemistry
Immunofluorescence staining was essentially performed as described previously (6, 12) ; transiently transfected HEK293 cells or MEF were grown on chamber-slides, fixed with methanol:acetone (1:1) at 2208C, 5 min, washed with PBS, preblocked with 5% BSA/PBS and incubated with primary antibodies against His or Myc epitope (1:500) in 1% BSA/PBS for 1 h at room temperature (RT). Slides were washed three times in PBS and incubated with Alexa Fluor 488 anti-mouse (Alexa) (1:500) in 1% BSA/PBS for 1 h at RT. Nuclei were stained with 4 0 ,6-diamidino-2-phenylindole (DAPI). After three washes with PBS, the slides were mounted with Mowiol/1,4-diazabicyclo(2,2,2)octan(DABCO), dried, and analyzed by fluorescence microscopy (Axiovert 200, Zeiss). To determine the frequency of inclusion formation in HEK293 cells, at least 100 transfected cells from randomly chosen fields of view were assessed for each experiment.
Pulse chase analysis
HEK293
cells were transfected with His-ATXN3Q19-wild-type, -S340A/S352A or -S340D/ S352D and after 24 h starved for 60 min with methionine/ cysteines-free Dulbecco's modified Eagle's medium plus 5% fetal bovine serum (Invitrogen), pulsed for 10 min with 35 S-methionine medium (25 mCi; Hartmann Analytik), washed twice with phosphate-buffered saline and chased in Dulbecco's modified Eagle's medium, supplemented with 2 mM methionine, 2 mM cysteine for 0 -16 h, followed by Ni-NTA pulldown and SDS-PAGE. The incorporated 35 S-methionine was quantified directly with a phosphoimager (Fuiji BAS 2000).
Luciferase reporter assay
For reporter assays, 1.5 Â 10 5 CSM14.1 cells per well were seeded on 24-well plates. Cells were transfected the next day with 200 ng of the previously described MMP-2 gene promoter reporter construct T1 (6) and the indicated ATXN3 constructs by FuGENE6 (Roche). The reporter construct was co-transfected with 0.4 ng of Renilla luciferase (pRL-CMV, Promega). After 48 h luciferase activities were measured by the dual-luciferase reporter assay system (Promega) in a luminometer (Berthold). Data were normalized to the activity of Renilla luciferase to account for transfection efficiency. Results are averaged from three independent experiments and presented as mean + SD, Ã a , 0.05 compared with empty vector; #a , 0.05 compared with WT.
